UTHRUnited Therapeutics Corporation
$549.48+32% 1Y
$549.48
$414.7352 weeks$596.76
The financials
United Therapeutics Corporation by the numbers
United Therapeutics Corporation (UTHR) reported revenue of $783M in Q2 2026 (quarter ended Jun 30, 2026), down 1.9% from the same quarter a year earlier. That came with a gross margin of 87% and net income of $333M (43% of revenue). For the full year FY2025, revenue was $3.18B (+11% year on year) and net income $1.33B. Its largest product in Q2 2026 was Tyvaso DPI at $327M, 42% of the disclosed total, well ahead of Remodulin at 16%. The next results filing is expected around Oct 28, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $783M | $799M | −1.9% |
| Gross profit | $684M | $711M | −3.8% |
| Operating income | $331M | $365M | −9.2% |
| Net income | $333M | $310M | +7.6% |
| Diluted EPS | $7.27 | $6.41 | +13% |
| Product | Revenue | Share |
|---|---|---|
| Tyvaso DPI | $327M | 42% |
| Remodulin | $126M | 16% |
| Nebulized Tyvaso | $126M | 16% |
| Orenitram | $126M | 16% |
| Unituxin | $65M | 8.3% |
| Product And Service Other | $6.8M | 0.9% |
| Adcirca | $6.7M | 0.9% |
Business segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Jun 2026Total $783.3M (+0.23%)
Product And Service Other grew +24% year on yearNebulized Tyvaso -18% year on year
Segment Latestquarter on quarteryear on year
- Tyvaso DPI$326.6M$326.6Mquarter on quarter -1.1%year on year +3.6%-1.1%+3.6%
- Remodulin$126.3M$126.3Mquarter on quarter -0.24%year on year -6.2%-0.24%-6.2%
- Nebulized Tyvaso$126.0M$126.0Mquarter on quarter -0.94%year on year -18%-0.94%-18%
- Orenitram$125.7M$125.7Mquarter on quarter -7.3%year on year +1.5%-7.3%+1.5%
- Unituxin$65.2M$65.2Mquarter on quarter +22%year on year +12%+22%+12%
- Product And Service Other$6.8M$6.8Mquarter on quarter +28%year on year +24%+28%+24%
- Adcirca$6.7M$6.7Mquarter on quarter +131%year on year +3.1%+131%+3.1%
Drug Manufacturers, Specialty & Generic
Ranks #2 of 41 by RyuScore